Article info
PDFCommentary
Pancreatic cancer surveillance and its ongoing challenges: is it time to refine our eligibility criteria?
- Correspondence to Dr Thomas P Potjer, Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; t.p.potjer{at}lumc.nl
Citation
Pancreatic cancer surveillance and its ongoing challenges: is it time to refine our eligibility criteria?
Publication history
- Received June 2, 2021
- Accepted June 3, 2021
- First published June 18, 2021.
Online issue publication
May 05, 2022
Article Versions
- Previous version (18 June 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.